enGene Therapeutics Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-09-08: Form 10-Q; Item Stock registered under Section 12(b); As filed Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ.
- 2026-06-15: Form 10-Q; Item Stock registered under Section 12(b); As filed Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ.
- 2026-03-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ.
- 2026-02-19: Form 10-K/A; Item Stock registered under Section 12(b); As filed Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ.
| Filed | Form | Item | As filed |
|---|
| 2026-09-08 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2026-06-15 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2026-03-09 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2026-02-19 | 10-K/A | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-12-22 | 10-K | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-09-11 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-06-12 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-03-10 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-02-20 | 10-K/A | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2025-02-20 | 10-K/A | Shell company | Yes |
|---|
| 2024-12-19 | 10-K | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2024-09-10 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2024-06-14 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2024-03-11 | 10-Q | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
| 2024-01-29 | 10-K | Stock registered under Section 12(b) | Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share · ENGNW · NASDAQ |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
|---|
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
|---|
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
|---|
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
|---|